丙种球蛋白联合甲基泼尼松龙治疗小儿急性重症支原体肺炎的临床效果

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (32 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To analyze the clinical effect of Gamma Globulin combined with Methylprednisolone in the treatment of Mycoplasma pneumonia in children.Methods From January 2015 to July 2016,84 children with acute severe Mycoplasma pneumonia in our hospital were selected and randomly divided into the observation group and the control group,42 cases in each group.Regular comprehensive therapies including oxygen uptake,cough and asthma relieving,phlegm expectoration,abatement of fever,liver protection were applied in both groups.Besides,participants in the observation group were treated by Gamma Globulin,Methylprednisolone,and Azithromycin,while in the control group,only Azithromycin was applied.The therapeutic effects of the two groups was compared.Results The total effective rate of the observation group was 92.86%,which was significantly higher than 69.05%of the control group,with significant difference(P＜0.05).The time of abating fever,cough disappearing,recovery of chest X-ray,and average hospital stay in the observation group was much shorter than that in the control group,with significant differences(P＜0.05).Conclusion Combination of Gamma Globulin and Methylprednisolone in the treatment of children with acute severe Mycoplasma pneumonia can remarkably improve patients′symptoms,which is worthy of clinical application and promotion.

Key words： Gamma globulin Methylprednisolone Pediatric Mycoplasma pneumonia

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LI Qing

Cite this article:

LI Qing. Clinical effect of Gamma Globulin combined with Methylprednisolone in the treatment of acute severe Mycoplasma pneumonia in children[J]. 中国当代医药, 2017, 24(27): 55-57.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2017/V24/I27/55

[1]	马友凤，唐军，李志博，等.丙种球蛋白对极低出生体重儿预防感染的临床研究[J].中华医院感染学杂志，2015，25（2）：455-457.
[2]	任明星，薛国昌，沈琳娜，等.甲泼尼龙联合阿奇霉素治疗小儿难治性支原体肺炎的疗效与安全性分析[J].中国全科医学，2015，18（5）：588-591.
[3]	朱春梅，曹玲.重症支原体肺炎并发症的诊治[J].中国实用儿科杂志，2015，30（3）：161-165.
[4]	农光民.肺炎支原体肺炎临床及影像学特点[J].中国实用儿科杂志，2015，30（3）：173-176.
[5]	王菲，尚云晓.肺炎支原体肺炎发病机制及相关临床问题[J].中国实用儿科杂志，2015，30（3）：184-189.
[6]	陈嘉慧，印根权，余嘉璐，等.红霉素与阿奇霉素治疗小儿肺炎支原体肺炎的临床研究[J].中国临床药理学杂志，2015，31（8）：587-589.
[7]	王臻，李雅春，陈璐.儿童难治性肺炎支原体肺炎的早期识别[J].中国当代儿科杂志，2015，17（11）：1189-1192.
[8]	施弦，郁峰，黄秋玲.支原体肺炎患儿的临床特点分析[J].中华医院感染学杂志，2014，24（1）：206-207，210.
[9]	潘国洪，严军平.不同剂量肾上腺皮质激素联合抗感染药物治疗儿科重症感染效果[J].中国医院药学杂志，2016，36（8）：666-669，686.
[10]	Mathew JL，Singhi S，Ray P，et al.Etiology of community acquired pneumonia among children in India：prospective，cohort study[J].J Glob health，2015，5（2）：050418.
[11]	肖喜庆，刘记，脱鸣富.痰热清注射液联合大环内酯类药物治疗小儿支原体肺炎的系统分析[J].儿科药学杂志，2014，20（8）：4-9.
[12]	李晓伟，黄先玫.人血丙种球蛋白对小儿难治性支原体肺炎的实效性评价[J].中国生化药物杂志，2016，36（10）：131-133.
[13]	梁航，李德丽，孟繁峥，等.丙种球蛋白联合阿奇霉素治疗难治性肺炎支原体肺炎的疗效观察[J].中国妇幼保健，2016，31（23）：5072-5075.
[14]	田茂强，张太海.大剂量丙种球蛋白与甲基泼尼松龙在重症手足口病的早期应用[J].中国中西医结合儿科学，2014，6（2）：156-157.
[15]	朱伟旺，李伟坚，黄慧.乌司他丁联合甲基泼尼松龙治疗急性呼吸窘迫综合征的效果分析[J].中国当代医药，2014，21（20）：100-101.